Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis
- PMID: 15747765
- PMCID: PMC1280107
Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis
Abstract
Objectives: To test the feasibility of human immune globulin (IG, Gamimune N, 10%) as a new treatment for endophthalmitis, the ocular tolerance, distribution, and ability of intravitreal IG to attenuate the toxic effects of Staphylococcus aureus culture supernatant were evaluated in a rabbit model.
Methods: Effects of intravitreally injected IG were assessed histologically and with Western blot analysis performed 1 to 5 days after injection. IG reactivity to products of S. aureus strain RN4220 was tested by Western blotting, using known toxins (beta hemolysin and toxic shock syndrome toxin-1) and a concentrated culture supernatant containing S. aureus exotoxins (pooled toxin, PT). Endophthalmitis was induced by intravitreal PT injection. For treatment, IG and PT were mixed and injected simultaneously, or IG was injected immediately after, or 6 hours after, PT injection. PT toxicity was graded clinically and histologically over 9 days.
Results: IG persisted intravitreally at least 5 days, inducing no clinical inflammation and minimal mononuclear cell infiltration. In the endophthalmitis model, toxicity from PT was significantly reduced when IG was mixed with PT and injected simultaneously, or when IG was delivered immediately after PT. Only minimal clinically detectable reductions were observed when IG delivery was delayed 6 hours.
Conclusions: Intravitreal IG is well tolerated in the rabbit eye and attenuates the toxicity of culture supernatant containing S. aureus exotoxins. Because toxin elaboration likely occurs gradually in true infection, reduced effects observed with delayed treatment in this toxin-injected model do not preclude clinical application. IG may represent a novel adjunct in endophthalmitis treatment.
Figures
















Similar articles
-
Intravitreally injected human immunoglobulin attenuates the effects of Staphylococcus aureus culture supernatant in a rabbit model of toxin-mediated endophthalmitis.Arch Ophthalmol. 2004 Oct;122(10):1499-506. doi: 10.1001/archopht.122.10.1499. Arch Ophthalmol. 2004. PMID: 15477462
-
Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.Am J Ophthalmol. 2005 Sep;140(3):497-504. doi: 10.1016/j.ajo.2005.04.015. Am J Ophthalmol. 2005. PMID: 16083841
-
Contribution of Leukocidin ED to the Pathogenesis of Staphylococcus aureus Endophthalmitis.Invest Ophthalmol Vis Sci. 2025 May 1;66(5):11. doi: 10.1167/iovs.66.5.11. Invest Ophthalmol Vis Sci. 2025. PMID: 40323270 Free PMC article.
-
Evaluation of Pseudomonas aeruginosa staphylolysin (LasA protease) in the treatment of methicillin-resistant Staphylococcus aureus endophthalmitis in a rat model.Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):913-7. doi: 10.1007/s00417-009-1061-2. Epub 2009 Mar 12. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19280208
-
Untargeted and temporal analysis of retinal lipidome in bacterial endophthalmitis.Prostaglandins Other Lipid Mediat. 2024 Apr;171:106806. doi: 10.1016/j.prostaglandins.2023.106806. Epub 2024 Jan 5. Prostaglandins Other Lipid Mediat. 2024. PMID: 38185280 Free PMC article. Review.
Cited by
-
Modeling intraocular bacterial infections.Prog Retin Eye Res. 2016 Sep;54:30-48. doi: 10.1016/j.preteyeres.2016.04.007. Epub 2016 May 3. Prog Retin Eye Res. 2016. PMID: 27154427 Free PMC article. Review.
-
Biocompatibility of pooled human immunoglobulin (Gamunex 10%™) with ocular infusion solutions (BSS™ and BSS Plus™): an in vitro evaluation of a potential antitoxin treatment for infectious endophthalmitis.J Ocul Pharmacol Ther. 2011 Aug;27(4):343-6. doi: 10.1089/jop.2011.0009. Epub 2011 Jun 1. J Ocul Pharmacol Ther. 2011. PMID: 21631364 Free PMC article.
-
The Pathogenesis of Staphylococcus aureus Eye Infections.Pathogens. 2018 Jan 10;7(1):9. doi: 10.3390/pathogens7010009. Pathogens. 2018. PMID: 29320451 Free PMC article. Review.
-
Intravenous immune globulin suppresses angiogenesis in mice and humans.Signal Transduct Target Ther. 2016;1:15002-. doi: 10.1038/sigtrans.2015.2. Epub 2016 Jan 28. Signal Transduct Target Ther. 2016. PMID: 26925256 Free PMC article.
References
-
- Endophthalmitis Vitrectomy Study Group. . Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479–1496. - PubMed
-
- Endophthalmitis Vitrectomy Study Group. . Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:830–846. - PubMed
-
- Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic factors isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1–17. - PubMed
-
- Kresloff MS, Castellarin AA, Zarbin M. Endophthalmitis. Surv Ophthalmol. 1998;43:193–224. - PubMed
-
- Waheed S, Ritterband DC, Greenfield DS, et al. New patterns of infecting organisms in late bleb-related endophthalmitis: a ten year review. Eye. 1998;12:910–915. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases